Compare Salesforce Inc (CRM) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Salesforce Inc vs Stryker Corporation — how do they compare? Salesforce Inc trades at $172.35 (market cap $137.23B), while Stryker Corporation trades at $313.87 (market cap $119.25B). The key difference: Salesforce Inc is the larger of the two by market cap, and Stryker Corporation pays the higher dividend (1.13%). Which is the better fit depends on your goals.
| CRM | SYK | |
|---|---|---|
Market Cap | $137.23B | $119.25B |
Sector | Technology | Technology |
52-Week High | $270.25 | $403.53 |
52-Week Low | $150.12 | $282.58 |
Enterprise Value | $167.28B | $131.01B |
Dividend Yield | 1.05% | 1.13% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Salesforce (CRM) trades at $171.28, showing minimal daily movement (+0.04%) amid recent market volatility. The stock demonstrates strong fundamentals with consistent earnings beats (Q1 2026 EPS of $3.88 vs. $3.13 expected) and robust profitability (77.64% gross margin). Technical indicators show mixed signals with bullish overall sentiment but bearish moving averages, while the stock trades near key support at $170. Recent news highlights AI momentum and market concerns about software sector performance.
CRM presents a compelling investment case with strong analyst support (76.84% buy rating) and significant upside to the $235.90 consensus target. However, investors face risks from sector-wide software selloffs, competitive AI landscape pressures, and the stock's 35% YTD decline requiring careful evaluation of growth sustainability versus current valuation discounts.
Stryker (SYK) trades at $331.45, up 0.51% today, with strong analyst support (74% buy ratings) and a consensus price target of $388.44. The stock shows bullish technical signals despite a recent Q1 2026 earnings miss attributed to a temporary cyber disruption. Fundamentals remain solid with 2025 revenue of $25.12B, net income margin of 13.21%, and robust cash flow generation of $5.04B from operations.
Outlook remains positive with maintained full-year guidance and healthy end-market demand. Investment opportunity lies in the valuation discount to historical averages and innovation-driven growth. Key risks include cybersecurity vulnerabilities and competitive pressures in the medtech sector. The stock offers potential upside of 17% to consensus target with dividend stability as a Dividend Aristocrat.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Salesforce Inc
Salesforce Inc provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group to deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.
Read more on CRM →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
